Table 3.
Species | Time (days) | Reduction in initial biofilm cell burden (in percentage, %RBB)* | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
TPU composites | PDMS composites | ||||||||||
P5 | P15 | P25 | P35 | P50 | S5 | S15 | S25 | S35 | S50 | ||
S. epidermidis | 2 | 64.1 ± 25.1 | 64.4 ± 32.9 | 86.3 ± 14.7a | 97.0 ± 1.3a | 97.7 ± 2.0a | 76.2 ± 25.8 | 83.3 ± 11.7 | 83.8 ± 17.5 | 92.4 ± 8.8a | 98.5 ± 0.9a |
5 | 67.9 ± 10.3 | 87.8 ± 3.7a | 98.7 ± 0.4a,c | 99.1 ± 0.2a,c | 98.9 ± 0.3a,c | 89.5 ± 10.8 | 92.5 ± 0.4a | 93.4 ± 3.6a | 95.6 ± 0.9a | 96.0 ± 4.3a | |
S. aureus | 2 | 67.9 ± 16.5 | 72.9 ± 20.2 | 62.8 ± 32.9 | 72.4 ± 28.4 | 79.6 ± 1.3a | 20.6 ± 11.7 | 20.4 ± 2.5 | 30.5 ± 6.6 | 22.5 ± 1.9 | 24.9 ± 6.7 |
5 | 61.6 ± 5.2 | 86.0 ± 6.9a | 92.4 ± 0.2a | 95.6 ± 3.1a,c | 97.9 ± 1.7a,b,c | 30.1 ± 5.3 | 78.0 ± 4.4 | 85.0 ± 2.1a | 90.2 ± 4.1a,b | 94,3 ± 4.1a,b | |
E. coli | 2 | 42.6 ± 11.6 | 60.2 ± 39.7 | 47.8 ± 19.6 | 39.1 ± 46.2 | 47.6 ± 26.7 | 46.2 ± 13.6 | 54.7 ± 2.4 | 60.8 ± 11.9 | 57.8 ± 16.5 | 66.9 ± 10.0 |
5 | 84.4 ± 4.4a | 88.5 ± 7.1a | 90.9 ± 5.9a,b | 87.0 ± 13.6a,b | 95.2 ± 4.8a,b | 88.3 ± 5.5a | 92.6 ± 7.5a,b | 89.9 ± 0.8a,b | 95.1 ± 1.7a,b | 92.0 ± 2.1a,b | |
P. aeruginosa | 2 | 46.8 ± 19.6 | 45.7 ± 33.3 | 59.9 ± 37.0 | 79.6 ± 0.8a | 80.6 ± 8.9a | — | — | — | — | — |
5 | 77.5 ± 26.0 | 76.1 ± 19.1 | 72.9 ± 17.8 | 83.7 ± 1.9a | 93.8 ± 3.7a | 34.7 ± 38.9b | 23.9 ± 48.5b | — | — | — |
acounts significantly lower than untreated polymers (p < 0.01).
bincrease in the antibiofilm activity on day 5 vs. day 2 (p < 0.01).
csignificantly more active than composites with 5 wt% of glass content.
*%RBB are calculated as the mean (±SD) reduction for each species (2 strains of S. epidermidis, 2 strains of S. aureus, 2 strains of E. coli and 2 strains of P. aeruginosa).